Navigation Links
New Study Indicates Changes in Cigarette Design Have Increased Lung Cancer Risk and Tobacco Regulation Can Greatly Reduce Lung Cancer
Date:5/1/2009

WASHINGTON, May 1 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L. Myers, President Campaign for Tobacco-Free Kids:

An important study presented Thursday at a scientific conference in Dublin, Ireland, provides powerful new evidence that U.S. smokers' risk of developing lung cancer has dramatically and progressively increased over the past four decades. In fact, cigarettes smoked today in the United States may double the risk of lung cancer compared to cigarettes smoked 40 years ago. The study also concludes that changes in cigarette design are the likely cause of this increased lung cancer risk and that regulation of tobacco products could significantly reduce lung cancer rates. The study concludes: "These data suggest that up to one half of current lung cancer occurrence may be attributable to changes in cigarette design and correspondingly that current lung cancer rates might be reduced by up to 50% through regulatory control of cigarette design and composition."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO)

The researchers' presentation and related materials can be found at: http://tobaccofreekids.org/campaign/burns_study/.

The study findings were presented at the 2009 Joint Conference of the Society for Research on Nicotine and Tobacco (SRNT) and SRNT-Europe in Dublin. The study was conducted by researchers David Burns and Christy Anderson of the University of California-San Diego School of Medicine. Dr. Burns is a well-known tobacco control scientist who has served as author, editor or senior revi
'/>"/>

SOURCE Campaign for Tobacco-Free Kids
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. K-State professor awarded $1.48 million to study LASIK complictions
2. New study evaluates community response to personally controlled health information
3. Home Study Course Teaches Health Care Professionals How to be Effective Experts & Defendants in Medical Malpractice Lawsuits
4. Pandemic study of 1918-1919 outbreak provides background and death rates for 14 European countries
5. Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis
6. Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
7. Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
8. Growth in Washington Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
9. Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
10. Growth in Utah Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
11. Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... between antidepressant prescriptions and the rates of suicide ... contradicts the Food and Drug Administration's "black box" ... known as SSRI drugs. ,The University of ... November issue of the American Journal of Psychiatry. ...
... test performed during pregnancies in the United States. Most ... guidelines from the American College of Obstetricians and Gynecologists. ... by the CDC that were based only on maternal ... amniocentesis increases the rate of miscarriage by 0.5% or ...
... of Kerala's economy has always been the tourism industry with ... all over the world. ,The latest buzzword in ... have cracked the winning combination of fun and well. ... experienced the boon of Kerala’s medical tourism. ,When ...
... making healthcare more affordable, over 880 medicines including common ... as antibiotics would become cheaper. ,The new pricing ... Thursday with the government fixing the wholesale and retail ... Chemicals and Fertiliser Ram Vilas Paswan said Tuesday that ...
... always gone back to nature and tapped its endless resources ... into the 'herbal' mode, not surprising that// scientists have drawn ... in circulation for thousands of years and may even assist ... from Type 2 diabetes. ,The herb named as ...
... identified a key enzyme responsible for triggering a chain ... new study findings published online// this week in Nature ... Commonwealth University, the Hospital for Special Surgery and Weill ... for development of new strategies and target therapies that ...
Cached Medicine News:Health News:Antidepressants Linked to Lower Child Suicide Rates 2Health News:Amniocentesis Safer for Pregnant Women 2Health News:Kerala to Venture into Medical Tourism 2Health News:Herbal Twist: Plausible Cure for Diabetes 'Crops' Up 2Health News:Key Signaling Switch Identified in Allergic Disease 2
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... (albinterferon alfa-2b) dosed every two weeks met the ... to peginterferon alfa-2a dosed weekly in patients with ... receiving 900-mcg Albuferon had comparable rates of serious ... Filing of global marketing applications planned in fall ...
... NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY), a ... anti-infective products for the treatment and prevention ... and viral infections without developing resistance, today ... the Company,s lead Aganocide(R) compound, was effective ...
Cached Medicine Technology:Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 2NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 3NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 4
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
... 1064 nm Nd:YAG Base Platform ... ophthalmologists treating the anterior segment ... the elimination of secondary cataracts ... Selecta platform offers multiple upgrade ...
Medicine Products: